JPWO2020227457A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020227457A5 JPWO2020227457A5 JP2021565723A JP2021565723A JPWO2020227457A5 JP WO2020227457 A5 JPWO2020227457 A5 JP WO2020227457A5 JP 2021565723 A JP2021565723 A JP 2021565723A JP 2021565723 A JP2021565723 A JP 2021565723A JP WO2020227457 A5 JPWO2020227457 A5 JP WO2020227457A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- bispecific antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024131038A JP2024170410A (ja) | 2019-05-08 | 2024-08-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962844959P | 2019-05-08 | 2019-05-08 | |
| US201962844966P | 2019-05-08 | 2019-05-08 | |
| US201962844976P | 2019-05-08 | 2019-05-08 | |
| US201962844995P | 2019-05-08 | 2019-05-08 | |
| US201962844970P | 2019-05-08 | 2019-05-08 | |
| US62/844,959 | 2019-05-08 | ||
| US62/844,966 | 2019-05-08 | ||
| US62/844,976 | 2019-05-08 | ||
| US62/844,995 | 2019-05-08 | ||
| US62/844,970 | 2019-05-08 | ||
| PCT/US2020/031749 WO2020227457A1 (en) | 2019-05-08 | 2020-05-07 | Materials and methods for modulating t cell mediated immunity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024131038A Division JP2024170410A (ja) | 2019-05-08 | 2024-08-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022533538A JP2022533538A (ja) | 2022-07-25 |
| JPWO2020227457A5 true JPWO2020227457A5 (https=) | 2023-05-16 |
| JP2022533538A5 JP2022533538A5 (https=) | 2023-05-16 |
| JP7686571B2 JP7686571B2 (ja) | 2025-06-02 |
Family
ID=73051172
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565723A Active JP7686571B2 (ja) | 2019-05-08 | 2020-05-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
| JP2024131038A Pending JP2024170410A (ja) | 2019-05-08 | 2024-08-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024131038A Pending JP2024170410A (ja) | 2019-05-08 | 2024-08-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11667712B2 (https=) |
| EP (1) | EP3965818A4 (https=) |
| JP (2) | JP7686571B2 (https=) |
| KR (1) | KR20220017892A (https=) |
| CN (1) | CN113966231B (https=) |
| AU (1) | AU2020267504A1 (https=) |
| BR (1) | BR112021022089A2 (https=) |
| CA (1) | CA3139508A1 (https=) |
| CL (1) | CL2021002905A1 (https=) |
| CO (1) | CO2021015998A2 (https=) |
| CR (1) | CR20210548A (https=) |
| DO (1) | DOP2021000229A (https=) |
| EC (1) | ECSP21087921A (https=) |
| IL (1) | IL287817A (https=) |
| JO (1) | JOP20210297A1 (https=) |
| MA (1) | MA55903A (https=) |
| MX (1) | MX2021013532A (https=) |
| PE (1) | PE20220763A1 (https=) |
| PH (1) | PH12021552790A1 (https=) |
| SG (1) | SG11202112021QA (https=) |
| TW (1) | TW202108618A (https=) |
| WO (1) | WO2020227457A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107531787B (zh) | 2015-01-27 | 2022-01-18 | 拉法医疗有限公司 | 靶向cd1d的单域抗体 |
| WO2020060406A1 (en) | 2018-09-19 | 2020-03-26 | Lava Therapeutics B.V. | Novel bispecific antibodies for use in the treatment of hematological malignancies |
| CA3145523A1 (en) * | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Therapeutic uses of anti-tcr delta variable 1 antibodies |
| KR20220147631A (ko) * | 2020-02-27 | 2022-11-03 | 얀센 바이오테크 인코포레이티드 | 면역 반응을 조절하기 위한 물질 및 방법 |
| US20210284731A1 (en) * | 2020-03-13 | 2021-09-16 | Janssen Biotech, Inc. | Methods and materials for modulating an immune response |
| CN116323667A (zh) | 2020-07-08 | 2023-06-23 | 拉法医疗股份有限公司 | 结合PSMA和γ-δT细胞受体的抗体 |
| AR123935A1 (es) | 2020-10-28 | 2023-01-25 | Janssen Biotech Inc | COMPOSICIONES Y MÉTODOS PARA MODULAR LA INMUNIDAD MEDIADA POR LA CADENA d g |
| US11639396B2 (en) * | 2021-02-16 | 2023-05-02 | Janssen Biotech, Inc. | Antibody binding to a linker peptide |
| MX2023009950A (es) | 2021-02-26 | 2023-11-10 | Lava Therapeutics N V | Anticuerpos que se unen a cd123 y receptores de linfocitos t gamma-delta. |
| IL326116A (en) * | 2023-07-26 | 2026-03-01 | Janssen Biotech Inc | Materials and methods for cell culture |
| TW202537974A (zh) * | 2023-11-15 | 2025-10-01 | 大陸商上海盛迪醫藥有限公司 | Ｔｒｇｖ９結合蛋白及其醫藥用途 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2698880B1 (fr) * | 1992-11-25 | 1995-02-24 | Inst Nat Sante Rech Med | Procédé de production de récepteurs T solubles, produits ainsi obtenus et leur utilisation dans des compositions diagnostiques ou thérapeutiques. |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| AU2002351208A1 (en) | 2001-12-03 | 2003-06-17 | Abgenix, Inc. | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| EP1789446A2 (en) | 2004-09-02 | 2007-05-30 | Genentech, Inc. | Heteromultimeric molecules |
| EP3050963B1 (en) | 2005-03-31 | 2019-09-18 | Chugai Seiyaku Kabushiki Kaisha | Process for production of polypeptide by regulation of assembly |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| US8871912B2 (en) | 2006-03-24 | 2014-10-28 | Merck Patent Gmbh | Engineered heterodimeric protein domains |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| KR20100058509A (ko) | 2007-07-31 | 2010-06-03 | 메디뮨 엘엘씨 | 다중특이적 에피토프 결합 단백질 및 이의 용도 |
| US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| JP2012505654A (ja) | 2008-10-14 | 2012-03-08 | ヤンセン バイオテツク，インコーポレーテツド | 抗体をヒト化及び親和性成熟する方法 |
| JP2012525149A (ja) | 2009-04-27 | 2012-10-22 | オンコメッド ファーマシューティカルズ インコーポレイテッド | ヘテロ多量体分子を作製するための方法 |
| US8728730B2 (en) | 2009-09-03 | 2014-05-20 | Genentech, Inc. | Methods for treating, diagnosing, and monitoring rheumatoid arthritis |
| DK2560993T3 (da) | 2010-04-20 | 2024-10-14 | Genmab As | Heterodimeric antibody fc-containing proteins and methods for production thereof |
| BR112013002831A2 (pt) | 2010-08-05 | 2016-11-01 | Anaptysbio Inc | anticorpos direcionados contra a il-17 |
| PL2635607T3 (pl) | 2010-11-05 | 2020-05-18 | Zymeworks Inc. | Projekt stabilnego przeciwciała heterodimerowego z mutacjami w domenie FC |
| MY169358A (en) | 2011-08-23 | 2019-03-26 | Roche Glycart Ag | Bispecific t cell activating antigen binding molecules |
| CA2854233C (en) | 2011-11-04 | 2020-05-12 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the fc domain |
| LT2794658T (lt) | 2011-12-19 | 2017-05-10 | Synimmune Gmbh | Bispecifinė antikūno molekulė |
| JP2016539929A (ja) * | 2013-10-25 | 2016-12-22 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 免疫療法のためのポリクローナルγδＴ細胞 |
| EP3129404B1 (en) | 2014-04-10 | 2026-01-28 | LAVA Therapeutics N.V. | Immunoglobulins binding human vgamma9vdelta2 t cell receptors |
| JO3568B1 (ar) * | 2014-09-05 | 2020-07-05 | Janssen Pharmaceutica Nv | عوامل ربط cd123 واستخداماتها |
| WO2016081518A2 (en) * | 2014-11-17 | 2016-05-26 | Adicet Bio, Inc. | Engineered gamma delta t-cells |
| MA44594B1 (fr) | 2015-05-29 | 2020-09-30 | Memorial Sloan Kettering Cancer Center | Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci |
| EP3560955A4 (en) | 2016-12-26 | 2020-12-23 | Kyowa Kirin Co., Ltd. | ANTIBODIES CAPABLE OF BINDING TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN |
| US11236145B2 (en) * | 2017-03-23 | 2022-02-01 | Immatics Biotechnologies Gmbh | T cell receptors and immune therapy using the same against PRAME positive cancers |
| US10519236B2 (en) * | 2018-01-23 | 2019-12-31 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| KR20220147631A (ko) | 2020-02-27 | 2022-11-03 | 얀센 바이오테크 인코포레이티드 | 면역 반응을 조절하기 위한 물질 및 방법 |
| US20210284731A1 (en) | 2020-03-13 | 2021-09-16 | Janssen Biotech, Inc. | Methods and materials for modulating an immune response |
| AR123935A1 (es) | 2020-10-28 | 2023-01-25 | Janssen Biotech Inc | COMPOSICIONES Y MÉTODOS PARA MODULAR LA INMUNIDAD MEDIADA POR LA CADENA d g |
-
2020
- 2020-05-07 EP EP20801607.1A patent/EP3965818A4/en active Pending
- 2020-05-07 MX MX2021013532A patent/MX2021013532A/es unknown
- 2020-05-07 AU AU2020267504A patent/AU2020267504A1/en not_active Abandoned
- 2020-05-07 CA CA3139508A patent/CA3139508A1/en active Pending
- 2020-05-07 US US16/869,401 patent/US11667712B2/en active Active
- 2020-05-07 PE PE2021001851A patent/PE20220763A1/es unknown
- 2020-05-07 BR BR112021022089A patent/BR112021022089A2/pt unknown
- 2020-05-07 TW TW109115171A patent/TW202108618A/zh unknown
- 2020-05-07 CR CR20210548A patent/CR20210548A/es unknown
- 2020-05-07 WO PCT/US2020/031749 patent/WO2020227457A1/en not_active Ceased
- 2020-05-07 JP JP2021565723A patent/JP7686571B2/ja active Active
- 2020-05-07 PH PH1/2021/552790A patent/PH12021552790A1/en unknown
- 2020-05-07 KR KR1020217036132A patent/KR20220017892A/ko not_active Ceased
- 2020-05-07 CN CN202080043002.2A patent/CN113966231B/zh active Active
- 2020-05-07 MA MA055903A patent/MA55903A/fr unknown
- 2020-05-07 SG SG11202112021QA patent/SG11202112021QA/en unknown
-
2021
- 2021-11-02 JO JOP/2021/0297A patent/JOP20210297A1/ar unknown
- 2021-11-03 IL IL287817A patent/IL287817A/en unknown
- 2021-11-04 CL CL2021002905A patent/CL2021002905A1/es unknown
- 2021-11-04 DO DO2021000229A patent/DOP2021000229A/es unknown
- 2021-11-26 CO CONC2021/0015998A patent/CO2021015998A2/es unknown
- 2021-12-03 EC ECSENADI202187921A patent/ECSP21087921A/es unknown
-
2023
- 2023-04-25 US US18/306,401 patent/US20240150464A1/en active Pending
-
2024
- 2024-08-07 JP JP2024131038A patent/JP2024170410A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210032357A1 (en) | Cd20 binding molecules and uses thereof | |
| KR102068600B1 (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| JP2021534096A5 (https=) | ||
| RU2019141289A (ru) | АНТИ-SIRPα АНТИТЕЛА | |
| JP2021531005A5 (https=) | ||
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| RU2018119165A (ru) | Антитело против лиганда 1 запрограммированной гибели клеток (pd-l1), его антигенсвязывающий фрагмент и их медицинское применение | |
| CN109843927A (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| JP2017529838A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2015509947A5 (https=) | ||
| JPWO2019224718A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| JP2020521504A (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| RU2019104980A (ru) | Анти-icos антитела | |
| RU2017114968A (ru) | Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171) | |
| JP2024024114A5 (https=) | ||
| JP2017521054A5 (https=) | ||
| CN115812081A (zh) | 抗ctla-4抗体及其用途 | |
| JP2020513759A5 (https=) | ||
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| JP2025511288A (ja) | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 |